Article Details

Bharat Biotech's intranasal COVID booster dose gets DCGI nod for restricted use

Retrieved on: 2022-11-25 10:05:07

Tags for this article:

Click the tags to see associated articles and topics

Bharat Biotech's intranasal COVID booster dose gets DCGI nod for restricted use. View article details on hiswai:

Excerpt

FILE — Vials of the Pfizer-BioNTech COVID-19 vaccine in Denver, Colo. on Feb. 28, 2021. Financial and bureaucratic barriers in the United States ...

Article found on: www.moneycontrol.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up